Business Combinations (Details) - Frame Pharmaceuticals B.v.Amsterdam Netherlands € / shares in Units, € in Thousands		12 Months Ended
Jun. 08, 2022 EUR (€)	Dec. 31, 2023 EUR (€) Option shares item Milestone € / shares	Jul. 01, 2022 shares
Business Combinations
Amount of fair value	€ 32,000
Net amount of discharging contractual obligations	1,560	€ 1,560
Number of payments in which the total consideration is to be paid \| item		3
Contingent consideration, Number of payments considered \| item		2
Issuance and transfer of shares to former Frame shareholders \| shares		810,242
Value of shares issued to former Frame shareholders		€ 11,040
Closing Share Price \| € / shares		€ 13.63
Issuance and transfer of shares as consideration for discharging the contractual obligations for the outstanding advisory agreements \| shares		48,254
Value of shares issued as consideration for discharging the contractual obligations for the outstanding advisory agreements		€ 658
Cash payments		585
Consideration paid in cash for the settlement of the vested employee options		335
Additional cash consideration		€ 250
Contingent consideration, Percentage of total consideration		50.00%
Contingent consideration, Number of milestones \| Milestone		2
Number of shares issued upon the achievement of the successful investigational new drug application filing \| shares		194,644
Percentage of consideration transferred upon the achievement of the successful investigational new drug application filing		10.00%
Value of shares issued upon the achievement of the successful investigational new drug application filing		€ 1,831
Number of shares issued upon successful proof of mechanism in humans \| shares		778,575
Percentage of consideration transferred upon successful proof of mechanism in humans		40.00%
Value of shares issued upon successful proof of mechanism in humans		€ 5,367
Contingent consideration, fair value		7,198
Total purchase price	€ 34,000	€ 19,481
Aggregate consideration in shares \| shares		858,496	858,496
Value of aggregate consideration in shares		€ 11,697
Value of shares issued to former Frame shareholders		€ 11,697
Contingent Consideration, Maximum shares issuable \| shares		973,236
RSUs issued to certain former employees \| Option		89,655
Total fair value of the RSU grant		€ 1,218
Number of tranches for vesting of RSUs granted \| item		3
Transactions costs		€ 500
Provisional fair value		6,216
Signing share price representing 10%		32,000
Signing share price representing 40%		32,000
net deferred tax liability		€ 20

The fair value, at acquisition date, of additional cash transferred as consideration in a business combination.

No definition available.

Name:	cvac_AdditionalCashTransferred
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of cash transferred in a business combination for the settlement of the vested employee options.

+ References

No definition available.

+ Details

Name:	cvac_CashTransferredForSettlementOfVestedEmployeeOptions
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Maximum number of shares issuable as contingent consideration in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_ContingentConsiderationMaximumSharesIssuable
Namespace Prefix:	cvac_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of milestones to be achieved under the contingent consideration arrangement under the business combination.

+ References

No definition available.

+ Details

Name:	cvac_ContingentConsiderationNumberOfMilestones
Namespace Prefix:	cvac_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of payments of total consideration under the business combination arrangement, that are subject to the achievement of defined milestones (contingent considerations).

+ References

No definition available.

+ Details

Name:	cvac_ContingentConsiderationNumberOfPaymentsConsidered
Namespace Prefix:	cvac_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of total consideration transferred under the business combination, that are subject to the achievement of defined milestones (contingent considerations).

+ References

No definition available.

+ Details

Name:	cvac_ContingentConsiderationPercentageOfTotalConsideration
Namespace Prefix:	cvac_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of fair value of total consideration transferred.

+ References

No definition available.

+ Details

Name:	cvac_FairValueOfTotalConsiderationTransferred
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_IfrsBusinessAcquisitionSharePrice
Namespace Prefix:	cvac_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount recognised as of the acquisition date for deferred tax liabilities net of deferred tax assets assumed in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_NetDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration for discharging the contractual obligations for the outstanding advisory agreements in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationForDischargingContractualObligations
Namespace Prefix:	cvac_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration to former shareholders in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationToFormerShareholders
Namespace Prefix:	cvac_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of first milestone in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfFirstMilestone
Namespace Prefix:	cvac_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of second milestone in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfSecondMilestone
Namespace Prefix:	cvac_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of payments in which the total consideration is to be paid under the business combination.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfPaymentsInWhichTotalConsiderationIsToBePaid
Namespace Prefix:	cvac_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of tranches for vesting of instruments granted in a share-based payment arrangement.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfTranchesForVestingOfInstrumentsGrantedInShareBasedPaymentArrangement
Namespace Prefix:	cvac_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of total consideration transferred under the business combination, upon the achievement of first milestone.

+ References

No definition available.

+ Details

Name:	cvac_PercentageOfConsiderationTransferredUponAchievementOfFirstMilestone
Namespace Prefix:	cvac_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of total consideration transferred under the business combination, upon the achievement of second milestone.

+ References

No definition available.

+ Details

Name:	cvac_PercentageOfConsiderationTransferredUponAchievementOfSecondMilestone
Namespace Prefix:	cvac_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of provisional fair value.

+ References

No definition available.

+ Details

Name:	cvac_ProvisionalFairValue
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount represents of signing share price representing 10%.

+ References

No definition available.

+ Details

Name:	cvac_SigningSharePriceRepresenting10
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount represents of signing share price representing 40%.

+ References

No definition available.

+ Details

Name:	cvac_SigningSharePriceRepresenting40
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration for discharging the contractual obligations for the outstanding advisory agreements in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationForDischargingContractualObligations
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration to former shareholders in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableAsConsiderationToFormerShareholders
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of first milestone in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfFirstMilestone
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration upon the achievement of second milestone in a business combination.

+ References

No definition available.

+ Details

Name:	cvac_ValueOfInstrumentsOrInterestsIssuedOrIssuableUponAchievementOfSecondMilestone
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph m
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_CashTransferred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfBusinessCombinationsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_EquityInterestsOfAcquirer
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The fair value, at acquisition date, of liabilities incurred (for example, a liability for contingent consideration) as consideration transferred in a business combination. [Refer: Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph f
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_iii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_LiabilitiesIncurred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.

+ References

+ Details

Name:	ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	ifrs-full_BusinessCombinationsAxis=cvac_FramePharmaceuticalsB.v.AmsterdamNetherlandsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: